Sponsored by:

Nuclear Medicine: Page 191

GE contributes $33M to R&D center in Wis.
By AuntMinnie.com staff writers
GE Healthcare has committed an investment of $32.9 million to build a state-of-the-art research facility in Wisconsin.
September 13, 2012
Nordion realigns into 2 business units
By AuntMinnie.com staff writers
Nordion is realigning to create two business units: Targeted Therapies and Specialty Isotopes. The Specialty Isotopes segment will include Sterilization Technologies and Medical Isotopes.
September 12, 2012
ASNC: U.S. cardiologists using less imaging
By AuntMinnie.com staff writers
U.S. cardiologists are seeing more patients than ever before, yet on average they are performing fewer advanced nuclear imaging tests on those patients, according to a new report from the American Society of Nuclear Cardiology (ASNC).
September 12, 2012
Navidea fails to get clearance for Lymphoseek
By AuntMinnie.com staff writers
The U.S. Food and Drug Administration has elected not to approve radiopharmaceutical developer Navidea Biopharmaceuticals' new drug application for its Lymphoseek radiopharmaceutical.
September 10, 2012
Digirad taps new CFO
By AuntMinnie.com staff writers
Nuclear medicine firm Digirad has appointed Jeffry Keyes as CFO, effective immediately.
September 10, 2012
JAMA: SPECT/CT works well to guide node excision
By Wayne Forrest
Using SPECT/CT scans to guide the excision of sentinel lymph nodes in melanoma patients produced both a greater rate of metastasis detection and higher disease-free survival rates, according to a study in the September 12 issue of the Journal of the American Medical Association.
September 10, 2012
Nordion loses case against AECL
By AuntMinnie.com staff writers
Nordion has lost its arbitration case against Atomic Energy of Canada (AECL) seeking damages from AECL's canceled construction of the MAPLE nuclear reactor facilities.
September 9, 2012
ImaginAb inks deal with MacroGenics
By AuntMinnie.com staff writers
Imaging agent developer ImaginAb has entered into a collaboration and commercialization agreement with MacroGenics to develop an anti-CD3 clinical imaging product, for which MacroGenics may receive future milestones and royalties.
September 9, 2012
Eckert & Ziegler to acquire Vitalea Science
By AuntMinnie.com staff writers
Eckert & Ziegler's Californian subsidiary, Eckert & Ziegler Isotope Products, has signed an agreement to purchase of all of Vitalea Science's stock and assets.
September 9, 2012
IBA Molecular creates 2 centers of excellence
By AuntMinnie.com staff writers
Radiopharmaceutical provider IBA Molecular has created two centers for innovation designed for advanced radiopharmaceutical contract development and manufacturing.
September 9, 2012
FDA calls out Lilly on Amyvid images
By AuntMinnie.com staff writers
The U.S. Food and Drug Administration is admonishing Eli Lilly for posting what it called "misleading" multicolored images on its website illustrating results with the PET radiopharmaceutical Amyvid (florbetapir F-18 injection).
September 9, 2012
DraxImage, Positron to boost radiopharma supply
By AuntMinnie.com staff writers
Canadian radiopharmaceutical firm Jubilant DraxImage (JDI) said it is teaming with PET vendor Positron to increase the sourcing and supply of strontium-82 and rubidium-82 generators.
September 6, 2012
Previous Page
Page 191 of 440
Next Page